2,000
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A fresh look at an old vaccine: Does BCG have a role in 21st Century Canada?

, MD, MHSc, CCFP, FRCPC, , , &
Pages 230-236 | Published online: 01 Sep 2004

References

  • Connelly Smith K, Starke JR. Bacille Calmette-Guerin Vaccine. In Plotkin SA, Orenstein WA, Eds. Vaccines. (3rd edition). Philadelphia: WB Saunders Company; 1999. pp 111–133
  • Canadian Lung Association. Prevention of TB: BGC vaccine. [cited 2003 Nov 6]. Available from: http://www.lung.ca/tb/tbhistory/prevention/vaccine.html.
  • Houston S, Fanning A, Soskolne CL, Fraser N.The ef fectiveness of Bacillus Calmette-Guérin (BCG) vaccination against tuberculosis.Am J Epidemiol 1990; 131: 340–348.
  • Behr MA. BCG - different strains, different vaccines? Lancet lnf Dis. 2002; 2: 86–92.
  • Wines RC. Immunology of Bacille Calmette-Guerin and related topics. Clin lnfec Dis 2000; 31 (53): 559–63.
  • Young TK, Hershfield ES.A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians.Am J Public Health 1986; 76: 783–786.
  • Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineburg HV. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995; 96: 29–35.
  • Ferguson RG, Simes AB. BCG vaccination of Indian infants in Saskatchewan.Tubercle 1949; 30: 5–11.
  • Health Canada.Tuberculosis Prevention and Control: Publications and Educational Materials.Available from: http://www.hc-sc.gc.ca/pphb-dgspspkbpc-latb/pubs_e.html.
  • Fitzgerald JM. Management of adverse reactions to Bacille Calmette-Guerin Vaccine. Clin lnfec Dis 2000;31(Supp13):S75–76.
  • Houde C. Mycobacterium bovis sepsis in an infant with Human Immunodeficiency Virus infection. Ped lnf Dis J 1988; 7(00):810–811 .
  • Clancy L, Rieder HL, Enarson DA, Spinaci S.Tubercu-losis elimination in the countries of Europe and other industrialized countries. Eur Respir J. 19914: 1288–1295.
  • Enarson DA, Rouillon A.The epidemiological basis of tuberculosis control. In: Davies PDO, editor. Clinical Tuberculosis. 2nd ed. London: Chapman & Hall; 1998.
  • Rahman M, Sekimoto M, Takamtsu I, et al. Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epi 2001; 30: 380–385.
  • Scheifele D, Law B, Jadavji T, et al. Disseminated Bacille Calmette-Guérin infection: Three recent Canadian cases. Can Comm Dis Rep 1998; 24: 69–75.
  • Lone A,Wasz-Hockert 0, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications: estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics.Adv Tuberc Res 1984; 21: 107–193.
  • Jones JF, Ritenbaugh CK, Spence MA and Hayward A. Severe Combined Immunodeficiency among the Navajo. I. Characteristics of Phenotypes, Epidemiology and Population Genetics. Human Biology 1991;63(5)669–682.
  • Appelbaum FR. Bone marrow and stem cell transplantation. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, Eds. Harrison’s Principles of Internal Medicine. 15th ed. Toronto: McGraw-Hill; 2001: 739–744.
  • Dalai 1, Reid B, Doyle J, Freedman M, Calderwood S, Saunders F, Roifman CM. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplantation 2000; 25: 613–621.
  • O’Marcaigh AS, DeSantes K, Hu D, Pabst H, Horn B, Li L, Cowan MJ. Bone marrow transplantation for T-B-severe combined immunodeficiency disease in Athabasan-speaking native Americans. Bone Marrow Transplantation 2001; 27: 703–709.